Back to Journals » Drug Design, Development and Therapy » Volume 10

Paclitaxel plus valproic acid versus paclitaxel alone as second- or third-line therapy for advanced gastric cancer: a randomized Phase II trial

Total article views   HTML views PDF downloads Totals
9,230 Dovepress* 8,308+ 1,339 9,647
PubMed Central* 922 345 1,267
Totals 9,230 1,684 10,914
*Since 25 July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar